Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $52,440 - $238,188
-27,600 Reduced 14.53%
162,400 $400,000
Q2 2022

Aug 11, 2022

BUY
$2.13 - $9.01 $100,110 - $423,470
47,000 Added 32.87%
190,000 $464,000
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $753,610 - $1.04 Million
31,000 Added 27.68%
143,000 $4.07 Million
Q2 2021

Aug 12, 2021

BUY
$26.09 - $40.4 $443,530 - $686,800
17,000 Added 17.89%
112,000 $3.78 Million
Q4 2020

Feb 16, 2021

SELL
$39.09 - $57.4 $926,667 - $1.36 Million
-23,706 Reduced 19.97%
95,000 $3.97 Million
Q3 2020

Nov 09, 2020

SELL
$28.43 - $44.67 $505,627 - $794,455
-17,785 Reduced 13.03%
118,706 $5.15 Million
Q2 2020

Aug 12, 2020

BUY
$11.71 - $30.29 $743,479 - $1.92 Million
63,491 Added 86.97%
136,491 $4.13 Million
Q1 2020

May 13, 2020

BUY
$7.64 - $27.5 $53,480 - $192,500
7,000 Added 10.61%
73,000 $998,000
Q4 2019

Feb 11, 2020

BUY
$15.02 - $20.57 $300,400 - $411,400
20,000 Added 43.48%
66,000 $1.07 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $780,312 - $1.18 Million
44,923 Added 4171.12%
46,000 $1.08 Million
Q1 2019

May 10, 2019

SELL
$10.65 - $25.75 $478,429 - $1.16 Million
-44,923 Reduced 97.66%
1,077 $46 Million
Q2 2018

Aug 10, 2018

BUY
$4.87 - $8.42 $224,020 - $387,320
46,000 New
46,000 $338,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.